Understanding Your Fertility Diagnostic Results

How to Understand Fertility Diagnostic Results

Fertility diagnostic results are best understood as individual pieces of a larger reproductive picture. Some tests evaluate ovarian reserve, some provide information about ovulation or reproductive hormones, and others assess sperm, the uterus, fallopian tubes or embryo development.

A result outside a laboratory’s reference range does not necessarily mean that pregnancy is impossible or that fertility treatment will be required. Likewise, a result within a reference range cannot by itself establish that there are no fertility barriers. The significance of a finding depends on what was tested, when the test was performed and how the result fits with the rest of the evaluation.

Age is also important when interpreting many fertility results. For example, AMH and antral follicle count primarily provide information about ovarian reserve and expected response to stimulation, while age is more strongly associated with egg quality and embryo chromosome status. Semen analysis requires a similarly comprehensive approach because sperm concentration, motility, morphology and semen volume provide different but related information.

Your Spring Fertility physician can help distinguish between a result that requires additional evaluation, one that may influence treatment planning and one that simply provides useful context. The goal is not to treat an isolated number, but to understand what the complete fertility evaluation tells us about your individual circumstances.

Types of Fertility Diagnostic Results

Fertility evaluation and treatment can produce several different categories of results. Understanding what each category measures can make individual findings easier to interpret.

• Ovarian reserve results: AMH, antral follicle count and FSH can provide information about ovarian reserve and anticipated response to fertility medications.
• Hormone and ovulation results: Estradiol, progesterone and other hormone testing may provide information about ovarian function, ovulation or response during treatment.
• Semen analysis results: Sperm concentration, total count, motility, morphology, semen volume and total motile sperm count provide different measures of semen and sperm health.
• Uterine and tubal results: Tests such as an HSG can provide information about the uterine cavity and whether the fallopian tubes appear open.
• IVF laboratory results: Egg maturity, fertilization, embryo development, blastocyst formation and embryo quality provide information about what occurred at different stages of an IVF cycle.
• Embryo genetic testing results: When PGT-A is performed, embryos may receive results such as euploid, aneuploid or mosaic based on chromosome findings in the cells sampled.

These categories frequently overlap. For example, ovarian reserve testing may help predict response before IVF, while the number of eggs retrieved and subsequent embryo development provide additional information once treatment occurs. Looking across these results can help your Spring Fertility physician understand not only where you started, but also how your reproductive biology responded during treatment.

Why Fertility Test Results Are Interpreted Together

Fertility depends on multiple parts of the reproductive process working together, which is why a single test result rarely provides a complete explanation of someone’s fertility. Ovarian reserve, ovulation, reproductive hormones, sperm, the uterus and fallopian tubes can each contribute different information, while IVF treatment can provide additional insight into egg maturity, fertilization and embryo development.

Results can also influence how other findings are interpreted. For example, a low AMH result provides information about ovarian reserve but does not directly measure egg quality. Age adds important context about expected egg quality, while antral follicle count and previous response to ovarian stimulation can provide additional information about egg quantity and expected treatment response.

The same principle applies to male fertility. A low sperm count may have different implications depending on sperm motility, morphology, semen volume and total motile sperm count. Similarly, an abnormal HSG finding needs to be considered alongside ovulation, ovarian reserve, sperm factors and reproductive history rather than viewed as an isolated explanation for difficulty conceiving.

Your Spring Fertility physician can bring these different pieces together to identify which findings are most clinically meaningful and whether they suggest a potential barrier to pregnancy. This comprehensive interpretation helps ensure that recommendations are based on your overall reproductive picture rather than any single number or test result.

What Happens After Your Fertility Test Results?

What happens next depends on your results, reproductive history, age and family-building goals. For some patients, testing is reassuring and no additional diagnostic evaluation is needed. For others, a result may lead to repeat testing, additional evaluation or a discussion about fertility treatment.

Your physician may also recommend addressing a specific finding before moving forward. For example, an abnormal uterine or tubal result may warrant additional evaluation, irregular ovulation may lead to investigation of an underlying cause, and significant semen analysis abnormalities may prompt additional male fertility testing. Patients undergoing IVF may instead be reviewing results from egg retrieval, fertilization, embryo development or PGT-A to determine what was learned from a treatment cycle.

Not every abnormal result requires treatment, and not every fertility treatment decision can be made from testing alone. At Spring Fertility, diagnostic results are considered alongside your priorities and reproductive timeline to determine which next step makes sense for you. Depending on your circumstances, that may include continued attempts to conceive, additional monitoring, ovulation induction or IUI, IVF, fertility preservation or another individualized treatment strategy.